adverse effects of tirzepatide Side Effects: What to Expect (and When to Worry) Incidence of mild and severe

Eluxadoline benefits patients with irritable bowel syndrome with diarrhea in a phase 2 study

In 2024, the FDA finalized a rule identifying ipamorelin as a drug substance that cannot be used in compounding under 503A or 503B because it does not meet the criteria for inclusion on the bulk drug substances list

Food intolerances mean that your body is unable to digest a specific food or particle in a food, such as lactose or gluten

Their guidelines recommended that countries and pharma companies implement several strategies to try to expand access, such as pooled procurement, tiered pricing, and voluntary licensing of what are now patented formulations to local manufacturers